Annual Cash & Cash Equivalents
$4.58B$291.85M-5.99%
Summary
- Current Value
- As of today, GSK annual cash & cash equivalents is $4.58B, down -5.99% on
- Historical Performance
- GSK annual cash & cash equivalents is down -51.65% over the past 3 years, and down -47.39% over the past 5 years
- All-Time High Comparison
- GSK annual cash & cash equivalents is currently -59.13% below its historical high of $11.21B set on
- 3-Year Low Comparison
- GSK annual cash & cash equivalents is at its 3-year low
- Sector Comparison
- GSK annual cash & cash equivalents is higher than 98.30% of companies in Healthcare sector
Cash and Cash Equivalents Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual Cash & Cash Equivalents | $4.58B | -6.0% | -51.6% | -47.4% | -53.8% | |
| Quarterly Cash & Cash Equivalents | $4.58B | -6.0% | -51.6% | -47.4% | – | |
| Price | $58.48 | +60.4% | +63.2% | +61.4% | +50.4% | |
| Annual Current Assets | $23.55B | +10.6% | -5.7% | -14.9% | -6.2% | |
| Annual Total Liabilities | $60.66B | +4.4% | +0.8% | -25.6% | +19.3% | |
| Annual Working Capital | -$5.22B | +11.3% | -112.6% | -100.9% | -202.8% | |
| Annual Net Income | $8.29B | +119.8% | +36.7% | +1.2% | +189.8% |
Cash and Cash Equivalents Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $9.48B | N/A | -51.6% |
| 5Y | $9.48B | -51.6% | |
| All | $11.21B | -59.1% |
Cash and Cash Equivalents Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $4.58B | at low | |
| 5Y | $4.58B | at low | |
| All | $37.03M | >+9999.0% |
Cash and Cash Equivalents History
FAQ
What is the current annual cash & cash equivalents of GSK?
As of today, GSK annual cash & cash equivalents is $4.58B
What is 1-year change in GSK annual cash & cash equivalents?
GSK annual cash & cash equivalents is down -5.99% year-over-year
What is 3-year change in GSK annual cash & cash equivalents?
GSK annual cash & cash equivalents is down -51.65% over the past 3 years
How far is GSK annual cash & cash equivalents from its all-time high?
GSK annual cash & cash equivalents is currently -59.13% below its historical high of $11.21B set on December 31, 2009
How does GSK annual cash & cash equivalents rank versus sector peers?
GSK annual cash & cash equivalents is higher than 98.30% of companies in Healthcare sector
When is GSK next annual earnings release?
As of today, the next annual earnings release for GSK has not been scheduled
Quarterly Cash & Cash Equivalents
$4.58B$130.54M+2.93%
Summary
- Current Value
- As of today, GSK quarterly cash & cash equivalents is $4.58B, up +2.93% on
- Historical Performance
- GSK quarterly cash & cash equivalents is down -5.99% year-over-year, and down -51.65% over the past 3 years
- All-Time High Comparison
- GSK quarterly cash & cash equivalents is currently -70.51% below its historical high of $15.54B set on
- 3-Year Low Comparison
- GSK quarterly cash & cash equivalents is +21.49% above its 3-year low of $3.77B reached on
- Sector Comparison
- GSK quarterly cash & cash equivalents is higher than 98.46% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly Cash & Cash Equivalents | $4.58B | +2.9% | -6.0% | -51.6% | -47.4% | |
| Annual Cash & Cash Equivalents | $4.58B | – | -6.0% | -51.6% | -47.4% | |
| Price | $58.48 | +23.5% | +60.4% | +63.2% | +61.4% | |
| Quarterly Current Assets | $23.55B | -1.9% | +10.6% | -5.7% | -14.9% | |
| Quarterly Total Liabilities | $60.66B | -1.2% | +4.4% | +0.8% | -25.6% | |
| Quarterly Working Capital | -$5.22B | -11.0% | +11.3% | -112.6% | -100.9% | |
| Quarterly Net Income | $966.83M | -66.6% | +50.6% | -49.3% | -12.7% |
Quarterly Cash & Cash Equivalents Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $5.79B | -20.9% | |
| 3Y | $9.48B | N/A | -51.6% |
| 5Y | $10.37B | -55.8% | |
| All | $15.54B | -70.5% |
Quarterly Cash & Cash Equivalents Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $4.45B | +2.9% | |
| 3Y | $3.77B | +21.5% | |
| 5Y | $3.77B | +21.5% | |
| All | $37.03M | >+9999.0% |
Quarterly Cash & Cash Equivalents History
FAQ
What is the current quarterly cash & cash equivalents of GSK?
As of today, GSK quarterly cash & cash equivalents is $4.58B
What is GSK quarterly cash & cash equivalents most recent change?
GSK quarterly cash & cash equivalents was up +2.93% on December 31, 2025
What is 1-year change in GSK quarterly cash & cash equivalents?
GSK quarterly cash & cash equivalents is down -5.99% year-over-year
How far is GSK quarterly cash & cash equivalents from its all-time high?
GSK quarterly cash & cash equivalents is currently -70.51% below its historical high of $15.54B set on March 31, 2015
How does GSK quarterly cash & cash equivalents rank versus sector peers?
GSK quarterly cash & cash equivalents is higher than 98.46% of companies in Healthcare sector
When is GSK next earnings release?
The next earnings release for GSK is on
Cash and Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
Data Sources & References
- GSK Official Website www.gsk.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1131399/000165495426000892/0001654954-26-000892-index.htm
- GSK Profile on Yahoo Finance finance.yahoo.com/quote/GSK
- GSK Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/gsk